Non-Hodgkin's Lymphoma Clinical Trials

A listing of Non-Hodgkin's Lymphoma medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

 

Alabama

UPDATED

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study for the treatment of Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin or Lymphoma, T-Cell

Birmingham Alabama 35291-3300

A clinical research study of Bendamustine, Obinutuzumab, Polatuzumab Vedotin and Rituximab for the treatment of Lymphoma, Lymphoma B-Cell, Non-Hodgkin's or Follicular Lymphoma

Birmingham Alabama 35213

A clinical trial to evaluate treatments using TGR-1202 for patients with Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia or Peripheral T-Cell Lymphoma

Birmingham Alabama 35233

A Phase 1 clinical study for patients with Lymphoma, B-Cell, Non-Hodgkin's Lymphoma

Birmingham Alabama 35213

Patients are needed to participate in a clinical research study evaluating BAY80-6946 for the treatment of Lymphoma, Non-Hodgkin

View More ▼

Birmingham Alabama 35249

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Daphne Alabama 36526

A Phase 3 clinical study for patients with Follicular Lymphoma

Huntsville Alabama 35805

A clinical research study of Bendamustine, Obinutuzumab, Polatuzumab Vedotin and Rituximab for the treatment of Lymphoma, Lymphoma B-Cell, Non-Hodgkin's or Follicular Lymphoma

Huntsville Alabama 35805

A clinical research study of Ublituximab + TGR-1202 for the treatment of Chronic Lymphocytic Leukemia or Non-Hodgkin's Lymphoma

Huntsville Alabama 35805

A clinical trial to evaluate treatments using idelalisib, Rituximab and Placebo for patients with Indolent Non-Hodgkin's Lymphomas

Mobile Alabama 36604

A clinical trial to evaluate treatments using Arm A: Rituximab and Arm B: GA101 for patients with Indolent Non-Hodgkin's Lymphoma

Mobile Alabama 36608

A Phase 2 clinical study for patients with Indolent Non-Hodgkin Lymphoma

Mobile Alabama 36608

A Phase 3 clinical study for patients with Follicular Lymphoma

Mobile Alabama 36608

A Phase 3 clinical study for patients with Follicular Lymphoma

Mobile Alabama 36607

A Phase 3 clinical study for patients with Follicular Lymphoma

Mobile Alabama 36607

A Phase 3 clinical study for patients with Follicular Lymphoma

Mobile Alabama 36608

Patients are needed to participate in a clinical research study evaluating Bendamustine, GDC-0199; ABT-199; RO5537382 and Rituximab [MabThera/Rituxan] for the treatment of Follicular Lymphoma

Alaska

Anchorage Alaska 99503

Patients are needed to participate in a clinical research study evaluating BAY80-6946 for the treatment of Lymphoma, Non-Hodgkin

Arizona

Chandler Arizona 85224

A clinical trial to evaluate treatments using idelalisib, Rituximab and Placebo for patients with Indolent Non-Hodgkin's Lymphomas

Chandler Arizona 85224

A Phase 2 clinical study for patients with Lymphoma, Non-Hodgkin

Gilbert Arizona

A clinical trial to evaluate treatments for patients with Lymphoma

Glendale Arizona 85304

A Phase 2 clinical study for patients with Indolent Non-Hodgkin Lymphoma

Phoenix Arizona

A clinical trial to evaluate treatments using CAT-8015 (Moxetumomab Pasudotox) for patients with Pediatric Acute Lymphoblastic Leukemia (pALL)

View More ▼

Scottsdale Arizona 85259-5499

A clinical trial seeking patients for a research study of CB-839 for the treatment of Hematological Tumors

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Tucson Arizona 85710

A clinical research study of Lenalidomide and Rituximab for the treatment of Lymphoma, Non-Hodgkin

Tucson Arizona 85710

A clinical research study of Lenalidomide and Rituximab for the treatment of Lymphoma, Non-Hodgkin

Tucson Arizona 85715

A clinical research study of Pixantrone + Rituximab and Gemcitabine + Rituximab for the treatment of Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma or Follicular Grade 3 Lymphoma

Tucson Arizona 85745

A clinical research study of Pixantrone + Rituximab and Gemcitabine + Rituximab for the treatment of Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma or Follicular Grade 3 Lymphoma

Tucson Arizona 85719

Patients are needed to participate in a clinical research study evaluating Bendamustine, GDC-0199; ABT-199; RO5537382 and Rituximab [MabThera/Rituxan] for the treatment of Follicular Lymphoma

Tucson Arizona 85710

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Tucson Arizona 85715

Patients are needed to participate in a clinical research study of Ofatumumab and Bendamustine infusions (Arm A) and Bendamustine infusion (Arm B) to evaluate Lymphoma, Follicular

Arkansas

Bentonville Arkansas 72712

A clinical research study of Pixantrone + Rituximab and Gemcitabine + Rituximab for the treatment of Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma or Follicular Grade 3 Lymphoma

Fayetteville Arkansas 72703

A clinical research study of Pixantrone + Rituximab and Gemcitabine + Rituximab for the treatment of Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma or Follicular Grade 3 Lymphoma

Jonesboro Arkansas 72401

A clinical research study of Ublituximab + TGR-1202 for the treatment of Chronic Lymphocytic Leukemia or Non-Hodgkin's Lymphoma

California

UPDATED

Duarte California 91010-3000

Patients are needed to participate in a clinical research study for the treatment of Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin or Lymphoma, T-Cell

UPDATED

Stanford California 94305

Patients are needed to participate in a clinical research study for the treatment of Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin or Lymphoma, T-Cell

Anaheim California 90801

Patients are needed to participate in a clinical research study evaluating BAY80-6946 for the treatment of Lymphoma, Non-Hodgkin

Bakersfield California 93309

A clinical trial to evaluate treatments using idelalisib, Rituximab and Placebo for patients with Indolent Non-Hodgkin's Lymphomas

Berkeley California 94704

A clinical research study of Lenalidomide and Rituximab for the treatment of Lymphoma, Non-Hodgkin

View More ▼

Downey California 90241

A Phase 2 clinical study for patients with Indolent Non-Hodgkin Lymphoma

Duarte California 91010

A clinical research study of Bendamustine, Obinutuzumab, Polatuzumab Vedotin and Rituximab for the treatment of Lymphoma, Lymphoma B-Cell, Non-Hodgkin's or Follicular Lymphoma

Duarte California 91010

A clinical research study of Ublituximab + TGR-1202 for the treatment of Chronic Lymphocytic Leukemia or Non-Hodgkin's Lymphoma

Duarte California 91010

A clinical trial seeking patients for a research study for the treatment of B-cell Non-Hodgkin Lymphoma

Duarte California

A clinical trial to evaluate treatments for patients with Lymphoma

Duarte California 91010

A clinical trial to evaluate treatments using idelalisib, Rituximab and Placebo for patients with Indolent Non-Hodgkin's Lymphomas

Duarte California 91010

A Phase 1-2 Multi-Center Study Evaluating KTE-C19 in Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (NHL)

Duarte California 91010

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Encinitas California 92024

Patients are needed to participate in a clinical research study evaluating BAY80-6946 for the treatment of Lymphoma, Non-Hodgkin